ProjectALXNWD1840 – A multicenter, randomized, controlled, open-label, rater-blinded study to evaluate efficacy, safety,…

Basic data

Acronym:
ALXNWD1840
Title:
A multicenter, randomized, controlled, open-label, rater-blinded study to evaluate efficacy, safety, pharmokokinetics and pharmacodynamics of ALXN1840 versus standard of care in pediatric participants with Wilson disease
Duration:
15/03/2022 to 15/03/2027
Abstract / short description:
A multicenter, randomized, controlled, open-label, rater-blinded study to evaluate efficacy, safety, pharmokokinetics and pharmacodynamics of ALXN1840 versus standard of care in pediatric participants with Wilson disease.
Keywords:
Morbus Wilson
Liver
Leber
Kupferspeicherkrankheit

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Local organizational units

Paediatrics Department I and Polyclinic
University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes, Faculty of Medicine

Funders

Boston, Massachusetts, United States
Help

will be deleted permanently. This cannot be undone.